|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/127 | |
| A61K 31/4375 |
| (11) | Number of the document | 2968146 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14764361.3 |
| Date of filing the European patent application | 2014-03-15 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/029907 |
| Date | 2014-03-15 |
| (87) | Number | WO 2014/145187 |
| Date | 2014-09-18 |
| (30) | Number | Date | Country code |
| 201361792850 P | 2013-03-15 | US |
| (72) |
KAN, Pei, TW
TSENG, Yun-Long, TW
OU, Han, Chun, TW
|
| (73) |
Taiwan Liposome Company, Ltd.,
2F 3 Yuanqu Street Nangang District, Taipei City 11503,
TW
TLC Biopharmaceuticals, Inc., 611 Gateway Blvd., Suite 830, South San Francisco CA 94080, US |
| (54) | CONTROLLED DRUG RELEASE LIPOSOME COMPOSITION |
| CONTROLLED DRUG RELEASE LIPOSOME COMPOSITION |